WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004009030) ANGIOGENESIS INHIBITION BY CEPHALOTAXINE ALKALOIDS, DERIVATIVES, COMPOSITIONS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/009030    International Application No.:    PCT/US2003/022926
Publication Date: 29.01.2004 International Filing Date: 22.07.2003
IPC:
A61K 31/55 (2006.01)
Applicants: CHEMGENEX PHARMACEUTICALS LIMITED [US/US]; 3475 Edison Way, Suite M, Menlo Park, CA 94025 (US) (For All Designated States Except US).
BROWN, Dennis, M. [US/US]; (US) (For US Only)
Inventors: BROWN, Dennis, M.; (US)
Agent: TRECARTIN, Richard, F.; Dorsey & Whitney LLP, 4 Embarcadero Center, Suite 3400, San Francisco, CA 94111 (US)
Priority Data:
60/397,657 22.07.2002 US
Title (EN) ANGIOGENESIS INHIBITION BY CEPHALOTAXINE ALKALOIDS, DERIVATIVES, COMPOSITIONS AND USES THEREOF
(FR) INHIBITION DE L'ANGIOGENESE A L'AIDE D'ALCALOIDES DE CEPHALOTAXINE, DERIVES, COMPOSITIONS ET UTILISATION DE CEUX-CI
Abstract: front page image
(EN)The invention relates to compositions and methods useful in treating or preventing angiogenic disease. The invention provides for compositions comprising cephalotaxine alkaloids as antiangiogenic agents for treatment of a host with an angiogenic disease or for prophylactic treatment of a host to inhibit the onset or progression of an angiogenic disease.
(FR)L'invention concerne des compositions et des procédés servant au traitement et à la prévention de maladies angiogéniques. Les compositions selon l'invention contiennent des alcaloïdes de céphalotaxine servant d'agents antiangiogéniques dans le traitement d'un hôte atteint d'une maladie angiogénique, ou dans le traitement prophylactique d'un hôte de manière à inhiber le déclenchement ou la progression d'une maladie angiogénique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)